NASDAQ · DRIO

DarioHealth Corp.

$7.47 -$0.32 (-4.11%) 1D Market open
Session Pulse Overnight session 1 mentions on Wed No new SEC filings since Mon close its sector ranked 5/11 this week Full pulse →

Key Metrics

$56.96M
Market cap
P/E · TTM
Revenue · TTM
−$40.74M
Net income
EPS · TTM $-17.20
Dividend yield
Free cash flow −$25.44M
Beta · 1Y 0.32
EBITDA · TTM −$34.28M
Gross margin

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 22
    A material event was filed (Form 8-K).

    8-K - DarioHealth Corp. (0001533998) (Filer)

    RECEIPT: SEC FORM 8-K, TIMESTAMPED
  • Jul 22
    Offering paper hit the record (Form 424B5).

    424B5 - DarioHealth Corp. (0001533998) (Filer)

    RECEIPT: SEC FORM 424B5, TIMESTAMPED
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 18.6 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Jun 26
    The stock moved +14.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Jun 26
  • Jun 23
    From its Feb 27 high, the share price fell 50%.

    Peak close $11.97 on Feb 27; trough close $5.99 on Jun 23. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -50%
  • Apr 7
    The stock moved -16.5% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Apr 7

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap$56.96M
Enterprise value$67.88M
Shares outstanding7.3M
52-wk range$5.84 – $17.74
Avg volume · 20D13.7K
Net cash −$10.92M
Book value / share$26.34
IndustrySurgical & Medical Instruments & Apparatus
ExchangeNASDAQ
About DarioHealth Corp.
IPO dateMar 8, 2013
Employees165

DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №

Profitability

Gross
Operating
Net
FCF
ROE / ROIC -60.6% · -47.3%

Financial Health

Current ratio3.07
Quick ratio2.62
Debt / equity0.50
Debt / EBITDA -0.90
Net cash −$10.92M
Working capital$19.38M

Cash Flow · TTM

Operating CF −$25.29M
Capex −$142.00K
Free cash flow −$25.44M
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

2 / 9
Weak fundamentals · 2 of 9 signals passing

Altman Z-Score

Insufficient balance-sheet inputs

Graham Number vs Price

Requires positive earnings and book value
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings